Heron's Non-Opioid, Post-Operative Pain Drug Approved By FDA: Why This Is Important
GW Pharma's Epidiolex Label Expansion, EU Launch Key Growth Drivers In 2020
Heron's Non-Opioid, Post-Operative Pain Drug Approved By FDA: Why This Is Important
GW Pharma's Epidiolex Label Expansion, EU Launch Key Growth Drivers In 2020
Flexion Analysts Say Long-Delayed Zilretta Label Expansion A Relief For Investors
Needham: Aerie Pharma's FDA Agreement 'Re-Establishes A Clinical Path Forward' For Rhopressa